{"id":919227,"date":"2025-12-12T08:06:57","date_gmt":"2025-12-12T13:06:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/"},"modified":"2025-12-12T08:06:57","modified_gmt":"2025-12-12T13:06:57","slug":"holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/","title":{"rendered":"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Dec.  12, 2025  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>MoonLake Immunotherapeutics (MLTX)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against MoonLake Immunotherapeutics (\u201cMoonLake\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0MLTX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding SLK\u2019s purported superiority to monoclonal antibodies between <strong>March 10, 2024 and September 29, 2025<\/strong>. If you purchased MoonLake shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QW2kvwGm5BUrPXUG-RudcgRhijxl4gnJZkpnPuzgVL9kV4m4gM1pIDY0KVpoLAf84IpcK2i14-oCqJC7_c2oCxJGmEQe98aV6EEIlX7vgmw=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eFeMIGGeuH0yzCwo4VDVNaAhwB6mxoDgQMhwYu_lHz5VkoRq5oNuw37GM6WQWR4z2wLDhQaKNx68UV0zLf-8UaQm154G74rlhA81B7F_6dr2GCRqpZK1m--7KOjiPuf92HXbAucs-_8ihlhx_W4ss-zzVB-oxNoN6Jsv7xTow22ylG0qKSxoO0OqboWquK1g\" rel=\"nofollow\" target=\"_blank\"><u>www.holzerlaw.com\/case\/moonlake-immunotherapeutics\/<\/u><\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is December 15, 2025.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>DexCom, Inc. (DXCM)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against DexCom, Inc. (\u201cDexCom\u201d or the \u201cCompany\u201d) (NASDAQ: DXCM) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding design changes to DexCom\u2019s G6 and G7 between <strong>January 8, 2024 and September 17, 2025<\/strong>. If you purchased DexCom shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QW2kvwGm5BUrPXUG-RudcgRhijxl4gnJZkpnPuzgVL82DxWGGxJcO9EjOyXgt_tjFjNn2LE_NtycGlbuwuhwbvXqKXriGtc3JbhamjK4Vxo=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eFeMIGGeuH0yzCwo4VDVNaAhwB6mxoDgQMhwYu_lHz6ZiGnTecF4bSAhMkQDDUsd6btWHnVGOdnfyJpgXZ2jYXX8a-eB1zVk8zbE8tx8PuJ0rdLXS8X-Z6PMvzg-wIZ6\" rel=\"nofollow\" target=\"_blank\"><u>www.holzerlaw.com\/case\/dexcom\/<\/u><\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is December 26, 2025.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Synopsys, Inc. (SNPS)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action filed against Synopsys, Inc. (\u201cSynopsys\u201d or the \u201cCompany\u201d) (NASDAQ: SNPS) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding the economics of Synopsys\u2019s Design IP business between <strong>December 4, 2024 and September 9, 2025<\/strong>. If you purchased Synopsys shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QW2kvwGm5BUrPXUG-RudcgRhijxl4gnJZkpnPuzgVL_Yu-oTGFOn8k96fKkX-DWTKR268bJZHQJMr0bqrXDxxXZreHalveDdUnmToahC3Oc=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eFeMIGGeuH0yzCwo4VDVNaAhwB6mxoDgQMhwYu_lHz61nZjq3dYGJU3N3MAO7Pphi27XSpxn3frRdKQEtOJmrj_AUHEK5LPnPPJ67-KB8o3L_WYdz595v4M_nycszXNT\" rel=\"nofollow\" target=\"_blank\"><u>www.holzerlaw.com\/case\/synopsys\/<\/u><\/a> for more information.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is December 30, 2025.<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-ZCNsGZETZN35o0YTdhDdzhAo7W69eEo-zgABH0xf_4u4TEjhrCkhNqxCV8pV-C0XOYq1-tZz9LbuLAACWikSMgS11jbcPeh20IuBJQ0zgU=\" rel=\"nofollow\" target=\"_blank\">https:\/\/holzerlaw.com\/<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QW2kvwGm5BUrPXUG-RudcgRhijxl4gnJZkpnPuzgVL-Kz1E11h1kf6_Lez_gA0oYnVeIpH_ATfln4QqoincYtdIcGsE8GSF0RZOi2LVEm04=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjBjMjgzYmEtZGQyNi00MTExLTg2ZWEtYzE3Njg0M2EwZjZiLTExOTIzMzYtMjAyNS0xMi0xMi1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Dec. 12, 2025 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: MoonLake Immunotherapeutics (MLTX) The shareholder class action lawsuit filed against MoonLake Immunotherapeutics (\u201cMoonLake\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0MLTX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding SLK\u2019s purported superiority to monoclonal antibodies between March 10, 2024 and September 29, 2025. If you purchased MoonLake shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-919227","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Dec. 12, 2025 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: MoonLake Immunotherapeutics (MLTX) The shareholder class action lawsuit filed against MoonLake Immunotherapeutics (\u201cMoonLake\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0MLTX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding SLK\u2019s purported superiority to monoclonal antibodies between March 10, 2024 and September 29, 2025. If you purchased MoonLake shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the &hellip; Continue reading &quot;Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-12T13:06:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)\",\"datePublished\":\"2025-12-12T13:06:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/\"},\"wordCount\":528,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/\",\"name\":\"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=\",\"datePublished\":\"2025-12-12T13:06:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/","og_locale":"en_US","og_type":"article","og_title":"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS) - Market Newsdesk","og_description":"ATLANTA, Dec. 12, 2025 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: MoonLake Immunotherapeutics (MLTX) The shareholder class action lawsuit filed against MoonLake Immunotherapeutics (\u201cMoonLake\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0MLTX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding SLK\u2019s purported superiority to monoclonal antibodies between March 10, 2024 and September 29, 2025. If you purchased MoonLake shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the &hellip; Continue reading \"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-12T13:06:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)","datePublished":"2025-12-12T13:06:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/"},"wordCount":528,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/","name":"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=","datePublished":"2025-12-12T13:06:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDI0MSM3MzE1OTA5IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-upcoming-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-moonlake-immunotherapeutics-mltx-dexcom-inc-dxcm-and-synopsys-inc-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Holzer &amp; Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=919227"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919227\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=919227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=919227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=919227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}